[Pathogenic agent and host response].
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001500:BCG Vaccine; D002353:Carrier State / Q000453:epidemiology; D004197:Disease Reservoirs; D018562:Disease Transmission, Infectious / Q000517:prevention & control; D014943:Global Health; D054884:Host-Pathogen Interactions; D006801:Humans; D007917:Leprostatic Agents / Q000627:therapeutic use; D007918:Leprosy / Q000175:diagnosis / Q000453:epidemiology / Q000517:prevention & control / Q000635:transmission; D008826:Microbial Sensitivity Tests; D023421:Models, Animal; D009166:Mycobacterium leprae / Q000187:drug effects / Q000276:immunology / Q000502:physiology*; D009296:Nasal Cavity / Q000382:microbiology; D010523:Peripheral Nervous System Diseases / Q000209:etiology / Q000382:microbiology / Q000517:prevention & control; D015995:Prevalence; D012698:Serologic Tests
D000900:Anti-Bacterial Agents; D001500:BCG Vaccine; D007917:Leprostatic Agents